KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Current Deferred Revenue (2016 - 2026)

Evolent Health has reported Current Deferred Revenue over the past 11 years, most recently at $1.2 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 52.01% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, down 52.01%, while the annual FY2025 figure was $1.2 million, 52.01% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $1.2 million at Evolent Health, down from $1.9 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $18.1 million in Q2 2021 and troughed at $1.2 million in Q4 2025.
  • A 5-year average of $7.4 million and a median of $6.5 million in 2023 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: increased 24.16% in 2023 and later crashed 64.93% in 2024.
  • Year by year, Current Deferred Revenue stood at $11.9 million in 2021, then plummeted by 51.79% to $5.8 million in 2022, then rose by 24.16% to $7.1 million in 2023, then crashed by 64.93% to $2.5 million in 2024, then plummeted by 52.01% to $1.2 million in 2025.
  • Business Quant data shows Current Deferred Revenue for EVH at $1.2 million in Q4 2025, $1.9 million in Q3 2025, and $2.7 million in Q2 2025.